- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07612579
PROSEVO Trial (Propofol-Sevoflurane Delirium Target Trial Emulation)
The results of this study have significant implications for clinical practice and guideline development. The current European guideline on postoperative Delirium prevention (ESAIC 2024) explicitly identifies a lack of large, adequately powered studies comparing different anesthetic techniques and is therefore currently unable to provide clear recommendations on the selection of an optimal technique. This study will close this knowledge gap and thus support future guideline recommendations. The results could show that a particular anesthetic technique (e.g., propofol) is associated with a significantly lower risk of postoperative delirium; if so, this would have immediate implications for modifying standard anesthesia protocols in hospitals.
Furthermore, Delirium is a significant public health challenge in aging societies. With demographic aging, the number of older patients undergoing surgery is continuously increasing. The societal costs of Delirium are estimated at several billion euros per year in major industrialized nations. A reduction in the incidence of postoperative Delirium by just 10% through optimization of the anesthetic procedure would therefore have major health economic implications.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Claudia Spies, MD, Prof.
- Telefonnummer: +49 30 450 55 11 02
- E-post: claudia.spies@charite.de
Studiesteder
-
-
-
Berlin, Tyskland, 12203
- Rekruttering
- Department of Anesthesiology and Intensive Care Medicine (CBF), Charité - Universitätsmedizin Berlin
-
Hovedetterforsker:
- Sascha Treskatsch, MD, Prof.
-
Ta kontakt med:
- Sascha Treskatsch, MD. Prof.
- Telefonnummer: +49 30 450 55 15 22
- E-post: sascha.treskatsch@charite.de
-
Berlin, Tyskland, 13353
- Rekruttering
- Department of Anesthesiology and Intensive Care Medicine Berlin
-
Hovedetterforsker:
- Claudia Spies, MD, Prof.
-
Ta kontakt med:
- Claudia Spies, MD, Prof.
-
Underetterforsker:
- Maximilian Markus, MD
-
Underetterforsker:
- Hannah Zoe Wurm
-
Underetterforsker:
- Nils Daum, MD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
- Adult patients (≥18 years) at the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK) and the Department of Anesthesiology and Intensive Care Medicine (CBF) at Charité,
- undergoing elective surgery under general anesthesia
- with a planned surgery duration of ≥ 30 minutes
Beskrivelse
Inclusion Criteria:
- Adult patients (≥18 years) at the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK) and the Department of Anesthesiology and Intensive Care Medicine (CBF) at Charité,
- undergoing elective surgery under general anesthesia
- with a planned surgery duration of ≥ 30 minutes
In addition, the following conditions must be met:
- The surgery must be the patient's first surgery per hospital stay to avoid dependencies and repeated measurements of the same person within a short time frame;
- The surgeries take place at Charité between January 1, 2011, and December 31, 2025.
Exclusion Criteria:
Patients in any of the following situations are excluded:
- Cardiac surgery (this patient group requires specialized monitoring strategies and has postoperative delirium risk profiles that differ significantly from those of other types of surgery)
- preoperatively diagnosed delirium, defined as positive results on the Nursing Delirium Screening Scale (NU-DESC) or the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) during preoperative evaluations;
- severe preoperative cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score <15 points, or
- preoperatively documented severe dementia
- neurosurgical procedures (neurosurgical patients require specialized monitoring protocols and differ from other surgical patients in their postoperative delirium (POD) symptoms)
- Patients who were already admitted to intensive care units prior to their elective surgery (these patients already have increased mortality and a different risk profile)
- Patients who were already intubated or sedated prior to surgery (this group cannot undergo standardized POD screening)
- High preoperative risk for postoperative nausea and vomiting (PONV) (specifically, patients with documented PONV grade 3 or PONV grade 4 risk are excluded, as this group is indicated for anesthesia with propofol)
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of postoperative delirium I
Tidsramme: 01.01.2011 - 31.12.2025
|
The occurrence of postoperative delirium (yes/no) within the 5-day follow-up period, defined as a positive NU-DESC or CAM-ICU test result on at least one day of hospitalization.
|
01.01.2011 - 31.12.2025
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of postoperative delirium II
Tidsramme: 01.01.2011 - 31.12.2025
|
Incidence of postoperative delirium specifically in the recovery room
|
01.01.2011 - 31.12.2025
|
|
Delirium severity
Tidsramme: 01.01.2011 - 31.12.2025
|
Delirium severity according to the Delirium Detection Score (DDS)
|
01.01.2011 - 31.12.2025
|
|
Duration of delirium
Tidsramme: 01.01.2011 - 31.12.2025
|
Number of days with positive delirium screening results
|
01.01.2011 - 31.12.2025
|
|
Time to first occurrence of postoperative delirium
Tidsramme: 01.01.2011 - 31.12.2025
|
Time to first occurrence of delirium in days after surgery
|
01.01.2011 - 31.12.2025
|
|
Length of hospital stay
Tidsramme: 01.01.2011 - 31.12.2025
|
Length of hospital stay in days
|
01.01.2011 - 31.12.2025
|
|
Unplanned intensive care unit admission
Tidsramme: 01.01.2011 - 31.12.2025
|
Unplanned ICU admission by hospital records
|
01.01.2011 - 31.12.2025
|
|
30-day mortality
Tidsramme: 01.01.2011 - 31.01.2026
|
30-day mortality by hospital records
|
01.01.2011 - 31.01.2026
|
Samarbeidspartnere og etterforskere
Etterforskere
- Studieleder: Claudia Spies, MD, Prof., Charite University, Berlin, Germany
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- PROSEVO
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .